Dalfampridine
Product Images NDC 51407-246

4 FDA label images from Golden State Medical Supply, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dalfampridine (NDC 51407-246). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

51407 246 60ol

51407 246 60ol
Label for Dalfampridine extended-release tablets 10 mg, bottle containing 60 tablets, prescription only. The label includes NDC 51407-246, advises dispensing the Medication Guide, storage conditions, and warnings to keep medication out of reach of children. Manufactured by Intas Pharmaceuticals Limited and marketed by GSMS, Incorporated.*
FDA Label Image

Chemical Structure (Dalfa 01)

Chemical Structure (Dalfa 01)
Chemical structure diagram of the active ingredient Dalfampridine, showing a pyridine ring with an amino group attached at position 3.*
FDA Label Image

Figure 1 (Dalfa 02)

Figure 1 (Dalfa 02)
A bar graph comparing the percentage of patients achieving various levels of average percent increase in walking speed from baseline. It contrasts results between a placebo group (N=72) and a Dalfampridine 10 mg twice daily treatment group (N=224), with statistical p-values indicated for each walking speed threshold.*
FDA Label Image

Figure 2 (Dalfa 03)

Figure 2 (Dalfa 03)
A bar chart comparing the percentage of patients achieving various average percent increases in walking speed from baseline. It contrasts placebo (N=118) with Dalfampridine 10mg b.i.d. (N=119). The horizontal axis shows increasing thresholds of walking speed improvement, while the vertical axis shows the percentage of patients. P-values for each comparison are displayed above the bars.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.